LDHA and glioblastoma: As such, potent LDH inhibitors like 5-aminolevulinic Acid (5-ALA) and oxamate, an isosteric form of pyruvate that blocks LDHA activity by competing with pyruvate, abate glycolytic activity and energy production, leading to cell death in glycolysis-dependent GBM cells [35,36].